J. Meserve

发表

Development and Validation of a Scoring System to Predict Outcomes of Vedolizumab Treatment in Patients With Crohn's Disease.

John T. Chang, Siddharth Singh, B. Sands, 2018, Gastroenterology.

Open: Vedolizumab for Ulcerative Colitis: Treatment Outcomes from the VICTORY Consortium

Siddharth Singh, B. Sands, C. Siegel, 2018, The American Journal of Gastroenterology.

Changes in Vedolizumab Utilization Across US Academic Centers and Community Practice Are Associated With Improved Effectiveness and Disease Outcomes

Siddharth Singh, B. Sands, C. Siegel, 2019, Inflammatory bowel diseases.

Predictors and Management of Loss of Response to Vedolizumab in Inflammatory Bowel Disease.

Siddharth Singh, B. Sands, C. Siegel, 2018, Inflammatory bowel diseases.

Pathologist, meet Picasso! Virtual chromoendoscopy for detecting histologic remission in ulcerative colitis.

Siddharth Singh, J. Meserve, 2021, Gastroenterology.

Shorter Disease Duration Is Associated With Higher Rates of Response to Vedolizumab in Patients With Crohn’s Disease But Not Ulcerative Colitis

Siddharth Singh, B. Sands, C. Siegel, 2019, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

Paternal Exposure to Immunosuppressive and/or Biologic Agents and Birth Outcomes in Patients with Immune-Mediated Inflammatory Diseases.

C. Chambers, Siddharth Singh, W. Sandborn, 2021, Gastroenterology.

Retrospective Analysis of Safety of Vedolizumab in Patients With Inflammatory Bowel Diseases.

Siddharth Singh, B. Sands, C. Siegel, 2019, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

Predicting Response to Vedolizumab in Inflammatory Bowel Disease

P. Dulai, J. Meserve, Joseph Meserve, 2020, Frontiers in Medicine.

Comparative Safety and Effectiveness of Vedolizumab to Tumor Necrosis Factor Antagonist Therapy for Ulcerative Colitis

R. Xu, Siddharth Singh, B. Sands, 2020, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

Development and Validation of Clinical Scoring Tool to Predict Outcomes of Treatment With Vedolizumab in Patients With Ulcerative Colitis

John T. Chang, Siddharth Singh, B. Sands, 2020, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

Systematic review with meta‐analysis: safety and tolerability of immune checkpoint inhibitors in patients with pre‐existing inflammatory bowel diseases

Siddharth Singh, V. Annese, W. Sandborn, 2020, Alimentary pharmacology & therapeutics.

Predictors of Clinical and Endoscopic Response with Vedolizumab for the Treatment of Moderately-Severely Active Ulcerative Colitis: Results from the us Victory Consortium

Siddharth Singh, B. Sands, C. Siegel, 2017 .

DOP023 Predictors of clinical and endoscopic response with vedolizumab for the treatment of moderately-severely active ulcerative colitis: results from the US VICTORY consortium.

B. Sands, C. Siegel, W. Sandborn, 2017, Journal of Crohn's & colitis.

OP026 Comparative effectiveness of vedolizumab and TNF-antagonist therapy in ulcerative colitis: a multicentre consortium propensity score-matched analysis

B. Sands, C. Siegel, W. Sandborn, 2018 .

Disseminated Herpes Simplex Virus with Fulminant Hepatitis

J. Gnann, J. Meserve, Zaw Min, 2015, Case reports in hepatology.

Understanding Determinants of Patient Preferences Between Stool Tests and Colonoscopy for the Assessment of Disease Activity in Inflammatory Bowel Disease

Siddharth Singh, W. Sandborn, P. Dulai, 2020, Digestive Diseases and Sciences.